• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[光凝治疗弥漫性糖尿病性黄斑水肿后的视力预后及预后危险因素]

[Visual prognosis and prognostic risk factors after photocoagulation for diffuse diabetic macular edema].

作者信息

Ohkoshi Kishiko

机构信息

Department of Ophthalmology, St. Luke's International Hospital, Tokyo, Japan.

出版信息

Nippon Ganka Gakkai Zasshi. 2005 Apr;109(4):210-7.

PMID:15859151
Abstract

PURPOSE

To investigate the efficacy of photocoagulation for diffuse diabetic macular edema.

SUBJECTS AND METHODS

One hundred and fifty eyes with diffuse diabetic macular edema were treated by laser photocoagulation (grid pattern photocoagulation, in some instances combined with direct photocoagulation) and followed up more than 1 year. The visual prognosis of these cases was retrospectively studied.

RESULTS

The logarithm of the minimum angle of resolution (Log MAR) final visual acuity after photocoagulation was improved more than 0.2 levels in 62 eyes (41%) of a total 150 eyes, and in 60% of 87 eyes in which preoperative visual acuity had been less than 0.5. Average visual acuity after photocoagulation reached a plateau within three months after surgery, and 84% of the eyes with 0.5 or better preoperative visual acuity achieved 0.5 or better final visual acuity. There was correlation between visual prognosis and the following preoperative factors: preoperative visual acuity, hard exudates, fluorescein leakage, grid area, hyperlipidemia, and renal failure.

CONCLUSIONS

Grid photocoagulation as a treatment for diffuse diabetic macular edema is effective to improve or maintain visual acuity. Alternative treatment such as vitrectomy should be considered after three-month observation on the outcome of grid photocoagulation.

摘要

目的

探讨光凝治疗弥漫性糖尿病性黄斑水肿的疗效。

对象与方法

对150例弥漫性糖尿病性黄斑水肿患者的患眼行激光光凝治疗(格栅样光凝,部分联合直接光凝),并随访1年以上。对这些病例的视力预后进行回顾性研究。

结果

150眼中62眼(41%)光凝术后最小分辨角对数(Log MAR)视力提高超过0.2级,术前视力低于0.5的87眼中60%达到此效果。光凝术后平均视力在术后3个月内达到平台期,术前视力0.5及以上的患眼中84%最终视力达到0.5及以上。视力预后与以下术前因素相关:术前视力、硬性渗出、荧光素渗漏、格栅面积、高脂血症及肾衰竭。

结论

格栅样光凝治疗弥漫性糖尿病性黄斑水肿对提高或维持视力有效。在对格栅样光凝治疗效果进行3个月观察后,应考虑玻璃体切割术等替代治疗。

相似文献

1
[Visual prognosis and prognostic risk factors after photocoagulation for diffuse diabetic macular edema].[光凝治疗弥漫性糖尿病性黄斑水肿后的视力预后及预后危险因素]
Nippon Ganka Gakkai Zasshi. 2005 Apr;109(4):210-7.
2
[Long-term results of grid pattern photocoagulation for diffuse diabetic macular edema].[格栅样光凝治疗糖尿病性黄斑弥漫性水肿的长期结果]
Nippon Ganka Gakkai Zasshi. 2007 May;111(5):401-6.
3
[Grid laser photocoagulation in diffuse diabetic macular edema].[格栅激光光凝治疗弥漫性糖尿病性黄斑水肿]
Klin Monbl Augenheilkd. 2004 Jan;221(1):48-51. doi: 10.1055/s-2003-812638.
4
Combined modified grid and panretinal photocoagulation for diffuse diabetic macular edema and proliferative diabetic retinopathy.联合改良格栅与全视网膜光凝治疗弥漫性糖尿病性黄斑水肿和增殖性糖尿病视网膜病变。
Ophthalmic Surg Lasers. 2000 Jul-Aug;31(4):292-300.
5
[Evaluate the effectiveness of laser therapy in the treatment of diabetic maculopathy].评估激光治疗糖尿病性黄斑病变的有效性。
Pol Merkur Lekarski. 2013 Jun;34(204):351-4.
6
[A grid pattern type of photocoagulation in treatment of diabetic maculopathy--personal experience].[格栅样光凝治疗糖尿病性黄斑病变——个人经验]
Klin Oczna. 2000;102(3):183-6.
7
Effective treatment of diffuse diabetic macular edema by temporal grid pattern photocoagulation.颞侧格栅样光凝治疗弥漫性糖尿病性黄斑水肿的疗效观察
Ophthalmic Surg Lasers Imaging. 2004 Jul-Aug;35(4):270-80.
8
Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.改良格栅激光光凝术与玻璃体切割联合内界膜剥除术治疗糖尿病性黄斑水肿的比较
Am J Ophthalmol. 2005 May;139(5):795-801. doi: 10.1016/j.ajo.2004.12.017.
9
Subthreshold (invisible) modified grid diode laser photocoagulation in diffuse diabetic macular edema (DDME).阈下(不可见)改良格栅二极管激光光凝术治疗弥漫性糖尿病性黄斑水肿(DDME)
Ophthalmic Surg Lasers. 1999 Nov-Dec;30(9):706-14.
10
Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.玻璃体内注射贝伐单抗和/或黄斑光凝作为弥漫性糖尿病性黄斑水肿的一线治疗。
Retina. 2010 Nov-Dec;30(10):1638-45. doi: 10.1097/IAE.0b013e3181e1ed07.